Pediatrix Medical (MD) Cash from Financing Activities (2009 - 2026)

Pediatrix Medical has disclosed Cash from Financing Activities across 18 years of filings, most recently posting -$27.6 million for Q1 2026.

• In Q1 2026, Cash from Financing Activities fell 357.91% year-over-year to -$27.6 million; the TTM figure through Mar 2026 stood at -$129.1 million (down 33.47% YoY), while the FY2025 annual figure was -$107.5 million, down 642.11% from the prior year.
• Cash from Financing Activities advanced to -$27.6 million in Q1 2026, from -$68.6 million in the prior quarter.
• Over the last five years, Cash from Financing Activities for MD reached as high as $108.6 million in Q1 2023 and fell as low as -$256.5 million in Q1 2022.
• The 5-year median for Cash from Financing Activities is -$28.6 million (2025), against an average of -$39.0 million.
• Annual changes were most pronounced in 2022 — Cash from Financing Activities sank 63000.76% — and 2023, when it soared 142.33%.
• A 5-year view of Cash from Financing Activities shows it stood at -$86.3 million in 2022, then jumped by 94.5% to -$4.7 million in 2023, then decreased by 4.55% to -$5.0 million in 2024, then tumbled by 1282.99% to -$68.6 million in 2025, then soared by 59.74% to -$27.6 million in 2026.
• According to Business Quant data, Cash from Financing Activities over the past three periods registered -$27.6 million, -$68.6 million, and -$28.6 million for Q1 2026, Q4 2025, and Q3 2025 respectively.